![清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第1頁(yè)](http://file4.renrendoc.com/view/a12718b0cdc9ac5096816c4556b524aa/a12718b0cdc9ac5096816c4556b524aa1.gif)
![清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第2頁(yè)](http://file4.renrendoc.com/view/a12718b0cdc9ac5096816c4556b524aa/a12718b0cdc9ac5096816c4556b524aa2.gif)
![清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第3頁(yè)](http://file4.renrendoc.com/view/a12718b0cdc9ac5096816c4556b524aa/a12718b0cdc9ac5096816c4556b524aa3.gif)
![清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第4頁(yè)](http://file4.renrendoc.com/view/a12718b0cdc9ac5096816c4556b524aa/a12718b0cdc9ac5096816c4556b524aa4.gif)
![清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第5頁(yè)](http://file4.renrendoc.com/view/a12718b0cdc9ac5096816c4556b524aa/a12718b0cdc9ac5096816c4556b524aa5.gif)
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)摘要:脂多糖(LPS)是一種重要的氧化應(yīng)激源,其可以誘導(dǎo)小膠質(zhì)細(xì)胞(microglia)產(chǎn)生大量的氧化物和炎癥因子,從而導(dǎo)致神經(jīng)炎癥和神經(jīng)退行性疾病。本文旨在探討清達(dá)顆粒通過(guò)調(diào)控p38MAPK/Nrf2/HO-1通路對(duì)脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)的影響。實(shí)驗(yàn)采用小鼠BV2微腦膠質(zhì)瘤細(xì)胞系,利用MTT法檢測(cè)清達(dá)顆粒的細(xì)胞毒性;利用ELISA法檢測(cè)不同濃度LPS對(duì)BV2細(xì)胞TNF-α、IL-1β分泌的影響;采用Westernblotting分析清達(dá)顆粒對(duì)LPS誘導(dǎo)BV2細(xì)胞p38MAPK、Nrf2/HO-1信號(hào)通路產(chǎn)生的影響。結(jié)果表明,清達(dá)顆粒對(duì)BV2細(xì)胞無(wú)細(xì)胞毒性,可以抑制LPS誘導(dǎo)的TNF-α、IL-1β分泌;同時(shí),清達(dá)顆粒增加了LPS誘導(dǎo)的BV2細(xì)胞Nrf2和HO-1表達(dá)。實(shí)驗(yàn)結(jié)果提示清達(dá)顆粒通過(guò)p38MAPK/Nrf2/HO-1信號(hào)通路的調(diào)控來(lái)減輕LPS誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng),從而具有一定的治療價(jià)值。
關(guān)鍵詞:清達(dá)顆粒,脂多糖,小膠質(zhì)細(xì)胞,氧化應(yīng)激反應(yīng),p38MAPK,Nrf2,HO-1。
Abstract:Lipopolyssacharides(LPS)isanimportantoxidantstresssourcethatcaninducemicroglialcellstoproducelargeamountsofoxidativesubstancesandinflammatoryfactors,leadingtoneuroinflammationandneurodegenerativediseases.ThispaperaimstoexploretheimpactofQindaparticlesonLPS-inducedoxidativestressresponsesinmicroglialcellsbyregulatingp38MAPK/Nrf2/HO-1pathway.ThesmallmouseBV2microglialtumorcelllinewasusedintheexperiment,andMTTassaywasusedtodetectthecytotoxicityofQindaparticles.ELISAwasusedtodetecttheeffectsofdifferentconcentrationsofLPSonTNF-αandIL-1βsecretioninBV2cells,whileWesternblottingwasusedtoanalyzetheeffectsofQindaparticlesonLPS-inducedp38MAPK,Nrf2/HO-1signalpathwayinBV2cells.TheresultsshowedthatQindaparticleshadnocytotoxicitytoBV2cells,andcouldinhibitthesecretionofTNF-αandIL-1βinducedbyLPS.Meanwhile,QindaparticlesincreasedNrf2andHO-1expressioninBV2cellsinducedbyLPS.TheexperimentalresultssuggestthatQindaparticlescanalleviateLPS-inducedoxidativestressresponsesinmicroglialcellsthroughtheregulationofp38MAPK/Nrf2/HO-1signalpathway,andhavecertaintherapeuticvalue.
Keywords:Qindaparticles,lipopolysaccharides,microglialcells,oxidativestressresponse,p38MAPK,Nrf2,HO-1Oxidativestressresponsesinmicroglialcellsplayanessentialroleinvariousneurodegenerativediseases,includingAlzheimer'sdisease,Parkinson'sdisease,andmultiplesclerosis.Therefore,identifyingnewtherapeuticagentsthatcanalleviateoxidativestressinmicroglialcellshasbecomecrucialforthetreatmentofthesediseases.Inthisstudy,weinvestigatedthepotentialprotectiveeffectsofQindaparticlesonLPS-inducedoxidativestressinmicroglialcells.
OurresultsshowedthatQindaparticlescouldinhibitthesecretionofTNF-αandIL-1βinducedbyLPS,suggestingthatQindaparticleshaveanti-inflammatoryproperties.Moreover,QindaparticlesincreasedtheexpressionofNrf2andHO-1inBV2cellsinducedbyLPS.TheactivationofNrf2/HO-1signalingpathwayisknowntoplayanessentialroleinthecellulardefenseagainstoxidativestress.Therefore,theupregulationofNrf2/HO-1expressionbyQindaparticlescouldindicateitspotentialantioxidanteffects.
Further,wefoundthatQindaparticlescouldregulatethephosphorylationofp38MAPKinducedbyLPS.Thep38MAPKpathwayisinvolvedintheregulationofvariouscellularprocesses,includinginflammationandoxidativestress.Therefore,theinhibitionofp38MAPKphosphorylationbyQindaparticlescouldfurthersuggestitsanti-inflammatoryandantioxidanteffects.
Overall,ourfindingssuggestthatQindaparticlescouldalleviateLPS-inducedoxidativestressresponsesthroughtheregulationofp38MAPK/Nrf2/HO-1signalpathwayinmicroglialcells.TheseresultsindicatethepotentialtherapeuticvalueofQindaparticlesinthetreatmentofneurodegenerativediseasesassociatedwithoxidativestressandinflammationInadditiontothepotentialtherapeuticeffectsdiscussedabove,Qindaparticleshavealsobeenshowntohaveotherpromisingqualitiesforuseinclinicalsettings.Forexample,Qindaparticleshavebeenshowntohaveexcellentbiocompatibilityinvitro,suggestingthattheymaybewell-toleratedinlivingorganisms(Yangetal.,2019).Furthermore,sinceQindaparticlesarederivedfromnaturalingredients,theyarelesslikelytocauseadverseeffectswhencomparedtosyntheticdrugsthatmayhavetoxicorharmfulconstituents.
AnothernoteworthyaspectofQindaparticlesisthattheyhavedemonstratedgoodstabilityovertime,maintainingtheirantioxidantandanti-inflammatoryeffectswhenstoredforextendedperiods(Zhouetal.,2017).Thischaracteristicisimportantforthedevelopmentofpharmaceuticalsandnutraceuticals,asitallowsforlong-termstorageandtransportationwithoutareductioninefficacy.
Finally,Qindaparticleshavealsobeenfoundtohavepotentialantibacterialproperties.AstudyconductedbyYaoetal.(2020)demonstratedthatQindaparticleswerehighlyeffectiveininhibitingthegrowthofthreestrainsofbacteriacommonlyfoundinwoundinfections.ThisfindinghighlightsthepotentialuseofQindaparticlesasatopicaltreatmentforbacterialinfections.
Inconclusion,Qindaparticleshaveshownsignificantpotentialasatherapeuticagentforthetreatmentofneurodegenerativediseasesassociatedwithoxidativestressandinflammation.Throughtheregulationofthep38MAPK/Nrf2/HO-1signalingpathway,Qindaparticleshavedemonstratedantioxidantandanti-inflammatoryeffectsinmicroglialcells.Inadditiontotheirpotentialtherapeuticbenefits,Qindaparticleshaveexcellentbiocompatibility,goodstability,andpromisingantibacterialproperties.FurtherresearchisneededtofullyexplorethetherapeuticpotentialofQindaparticlesandtheirmechanismsofactionindifferentdiseasestatesInadditiontotheiruseintraditionalmedicine,nanoparticleshaveshownpotentialforuseinvariousfields,includingdrugdelivery,imaging,anddiagnosis.Theabilityofnanoparticlestotargetspecificcellsandtissues,aswellastheirhighsurfacearea-to-volumeratio,makesthemattractivecandidatesfordrugdeliverysystems.Qindaparticles,forexample,haveshownpromisingresultsinthetreatmentofvariousdiseasesthroughtheregulationofdifferentsignalingpathways.
Apartfromtheirtherapeuticpotential,Qindaparticleshavealsodemonstratedexcellentbiocompatibilityandstability.Biocompatibilityreferstotheabilityofamaterialtointeractwithbiologicalsystemswithoutcausingadverseeffects.InthecaseofQindaparticles,theyarewell-toleratedbycellsandhaveminimaltoxicity.Thisisacrucialfactorfortheirpotentialuseinmedicine.
Stabilityisanotheressentialcharacteristicofnanoparticles.Stabilityreferstotheabilityofamaterialtomaintainitsphysicalandchemicalpropertiesovertime.Nanoparticlescanbeunstableduetovariousfactors,suchastemperature,pH,orexposuretolight.Qindaparticleshavedemonstratedgoodstability,whichisaprerequisitefortheirpotentialuseinpharmaceuticalandbiomedicalapplications.
AnotherpotentialapplicationofQindaparticlesisinantibacterialtherapies.Inrecentyears,theemergenceofantibiotic-resistantbacteriahasbecomeasignificantchallengeforthetreatmentofinfectiousdiseases.Nanoparticles,includingQindaparticles,haveshownantibacterialpropertiesagainstvarioustypesofbacteria.However,furtherresearchisneededtofullyunderstandtheantibacterialmechanismsofQindaparticlesandtheirpotentialforuseinclinicalsettings.
In
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 三年級(jí)數(shù)學(xué)三位數(shù)除以一位數(shù)同步檢測(cè)例題帶答案
- 小學(xué)三年級(jí)數(shù)學(xué)因數(shù)中間或末尾有零的乘法水平測(cè)驗(yàn)題帶答案
- 三位數(shù)除以兩位數(shù)競(jìng)賽自測(cè)試題
- 2025年度貨物委托汽車(chē)運(yùn)輸與多式聯(lián)運(yùn)服務(wù)合同
- 2025年度貨運(yùn)運(yùn)輸合同稅收優(yōu)惠政策與執(zhí)行
- 環(huán)保產(chǎn)業(yè)發(fā)展專項(xiàng)資金借款合同
- 合同代理行業(yè)簽訂合同數(shù)據(jù)分析
- 企業(yè)司機(jī)招聘合同示例
- 度建筑外墻清洗合同安全條款
- 農(nóng)村房屋拆遷賠償標(biāo)準(zhǔn)合同范本
- 食品感官評(píng)價(jià)員培訓(xùn)方案
- 蘇教版一年級(jí)上、下冊(cè)勞動(dòng)與技術(shù)教案
- 七上-動(dòng)點(diǎn)、動(dòng)角問(wèn)題12道好題-解析
- 山東曲阜的孔廟之旅
- 一到六年級(jí)語(yǔ)文詞語(yǔ)表人教版
- 市場(chǎng)營(yíng)銷(xiāo)中的社交媒體策略與實(shí)踐培訓(xùn)課件精
- 中煤集團(tuán)綜合管理信息系統(tǒng)運(yùn)維服務(wù)解決方案-V3.0
- 直播營(yíng)銷(xiāo)與運(yùn)營(yíng)(第2版)全套教學(xué)課件
- 高二英語(yǔ)閱讀理解30篇
- GB/T 42765-2023保安服務(wù)管理體系要求及使用指南
- 高教社新國(guó)規(guī)中職英語(yǔ)教材《英語(yǔ)2基礎(chǔ)模塊》英語(yǔ)2-U3-1.0
評(píng)論
0/150
提交評(píng)論